Menopausal syndrome (MPS) creates a significant health burden as ovarian function declines, leading to vasomotor and metabolic instability. Consequently, many women seek alternatives to hormone replacement therapy due to safety concerns and adverse effects. Liuwei Dihuang pill menopause research is gaining traction as a potential integrative solution to improve patient outcomes. This traditional Chinese medicine formula specifically targets kidney-yin deficiency, which often manifests as hot flashes, insomnia, and anxiety. However, clinicians require more robust real-world evidence to confirm its efficacy when used alongside conventional Western protocols.

Evaluating the Liuwei Dihuang Pill Menopause Study Protocol

This prospective, multicenter, observational cohort study will enroll 1,000 patients across eight centers in China. The researchers will allocate participants into two groups: one receiving conventional therapy plus the Liuwei Dihuang pill and another receiving conventional therapy alone. Furthermore, the study will focus on the primary outcome of changes in the modified Kupperman Index over a four-week period. Additionally, the investigators plan to utilize propensity score-based weighting to ensure balanced baseline covariates. This methodology strengthens the reliability of the comparative analysis in a real-world clinical setting.

Beyond symptom relief, the trial will explore biological mechanisms through metabolomics and sex hormone analysis. Specifically, secondary outcomes include improvements in the Menopausal Quality of Life Scale and metabolic parameters. Notably, the study team will monitor safety by recording adverse events and abnormalities in laboratory parameters throughout the 2026-2027 timeline. Therefore, these results will offer a scientific foundation for standardizing this traditional formula in modern gynecological practice.

Frequently Asked Questions

How does the Liuwei Dihuang pill assist with menopausal symptoms?

In traditional medicine, the formula is believed to nourish kidney-yin, which helps regulate the hypothalamic-pituitary-ovarian axis. This regulation may stabilize estrogen fluctuations and reduce vasomotor symptoms like hot flashes and night sweats.

What are the primary outcomes measured in this clinical study?

The primary measurement is the change in the modified Kupperman Index, a standardized scale for assessing the severity of menopausal symptoms. Additionally, the study tracks quality of life scores and serum sex hormone levels.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Wei S et al. Real-World Effectiveness and Safety of Liuwei Dihuang Pill for Menopausal Syndrome: Protocol for a Prospective, Observational, Multicenter Cohort Study. JMIR Res Protoc. 2026 Mar 25. doi: 10.2196/84803. PMID: 41879810.

Zhang Y et al. Liuwei Dihuang, a traditional Chinese medicinal formula, inhibits proliferation and migration of vascular smooth muscle cells via modulation of estrogen receptors. Molecular Medicine Reports. 2017. doi: 10.3892/mmr.2017.6591.

Chen G. Clinical Study on Liuwei Dihuang pill to prevent bone loss in breast cancer patients caused by aromatase inhibitors. China Medical Frontier. 2013; 8: 59-60.